First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2001-03-15 10:04:58Open Document File Size: 130,15 KBShare Result on FacebookCityKansas City / /CompanyWellPoint Health Networks / M.P.H. / /ContinentEurope / /CountryUnited States / Canada / /Currencypence / /FacilityCalifornia Pharmacy / / /IndustryTermantihistamine/decongestant products / quality pharmaceutical care / /MedicalConditionallergy / nasal congestion / /MedicalTreatmentadjunctive therapy / /OrganizationFood and Drug Administration / Regulatory Policy Division / /PersonRob Seidman / Blue Cross / Marion Roussel / Douglas Schur / / /Positionphysician / Director of Regulatory Affairs / MPH Vice President / Vice President / /ProductAllegra / fexofenadine / /ProvinceOrStateMissouri / California / /PublishedMediumthe FDA review / /SocialTag |